778 APPENDIX B DRUG FORMULARY
Drug name (trade orother names)Pharmacology andindicationsAdverse effects andprecautionsDosing information andcommentsFormulationsDosage (unlessotherwise indicated,dose is the same fordogs and cat)Gentamicin sulfate(Gentocin)Aminoglycoside antibiotic.Action is to inhibitbacteria protein synthesisvia binding to 30Sribosome. Bactericidal.Broad spectrum of activityexcept streptococci andanaerobic bacteria.Nephrotoxicity is the mostdose-limiting toxicity.Ensure that patients haveadequate fluid andelectrolyte balance duringtherapy. Ototoxicity,vestibulotoxicity also arepossible.Druginteractions:Whenusedwith anesthetic agents,neuromuscular blockadeis possible. Do not mix invial or syringe with otherantibiotics.Dosing regimens arebasedonsensitivityoforganisms. Some studieshave suggested thatonce-daily therapy(combining multiple dosesinto a single daily dose) isas efficacious as multipletreatments. Activityagainst some bacteria(e.g.,Pseudomonas)isenhanced whencombined with aβ-lactamantibiotic. Nephrotoxicityis increased withpersistently high troughconcentrations.50 and 100 mg/mLsolution forinjection.Dog: 2–4 mg/kg q8h, or9–14 mg/kg q24h IV, IM,SC.Cat: 3 mg/kg q8h, or5–8 mg/kg q24h IV, IM,SC.Gold sodiumthiomalate(Myochrysine)Gold therapy (formechanism, seeAurothioglucose).See Aurothioglucose.Clinical studies have notbeen performed inanimals. Efficacy andsafety of this product arenot available for animals.Aurothioglucose generallyis used more often thanMyochrysine.10, 25 and50 mg/mL injection.1–5 mg IM on first week,then 2–10 mg IM onsecond week, then1 mg/kg once/week IMmaintenance.Gold therapySee Aurothioglucose,Gold sodium thiomalate,or Auranofin.